"Decitafect 50mg Injection is a pharmaceutical preparation containing DECITABINE as its active ingredient, classified under the Chemotherapy general category and the Chemotherapy speciality domain. Decitabine is a hypomethylating agent that inhibits DNA methyltransferase, leading to reactivation of silenced tumour suppressor genes and promoting differentiation or death of abnormal bone marrow cells. Manufactured by AUREATE HEALTHCARE PVT LTD. As with any prescription medicine, dosage and treatment duration must be individualised by the treating specialist based on the patient's diagnosis, disease stage, organ function, and concurrent medications.

Uses of Decitafect 50mg Injection
Used in the treatment of myelodysplastic syndromes (MDS) and acute myeloid leukaemia, particularly in patients who are not candidates for intensive chemotherapy.

Decitafect 50mg Injection containing DECITABINE works as described: Decitabine is a hypomethylating agent that inhibits DNA methyltransferase, leading to reactivation of silenced tumour suppressor genes and promoting differentiation or death of abnormal bone marrow cells. Therapeutically, it is classified under the Chemotherapy category and Chemotherapy speciality domain. Regular monitoring by the treating specialist is recommended to assess treatment response and manage side effects.

• Always inform your doctor about every medicine, supplement, or herbal product you are currently taking before starting Decitafect 50mg Injection. Caution with other myelosuppressive drugs; inform your doctor of all concurrent medications and monitor blood counts regularly.

Decitafect 50mg Injection is available under medical guidance and should be used strictly as advised by a licensed specialist. Storage: Store below 25°C. Protect from light. Disposal: Do not flush unused product or dispose of it in household waste; return unused or expired product to a licensed pharmacy. Manufactured by AUREATE HEALTHCARE PVT LTD and complies with applicable regulatory standards.